InvestorsHub Logo
Followers 1
Posts 261
Boards Moderated 0
Alias Born 09/11/2017

Re: guitar128 post# 9639

Thursday, 08/20/2020 10:38:19 PM

Thursday, August 20, 2020 10:38:19 PM

Post# of 9945
InMed hasn't delivered anything but power point presentations along w/a massive share consolidation up to this point so I wouldn't get too cocky now on us. They also have zero patent protection even though they've been at this for years which is rather hard to believe.

InMed lost at least a year when their primary biosynthetic pathway was grounded so it's very possible that some of their peers have caught up or passed them by now. I have more faith in Ginkgo/CRON and Willow at this point to get to commercialization. InMed is still prioritizing this program to support their internal pipeline over broader commercialization. I'm more interested in those that are prioritizing the manufacturing of cannabinoids first and foremost for revenue generation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News